Inclusion of "pharmacist" on OTC label warnings supported by majority of cmte. members.
This article was originally published in The Tan Sheet
Executive Summary
"PHARMACIST" INCLUSION IN OTC LABEL WARNINGS endorsed by a majority of the members of FDA's Nonprescription Drugs Advisory Committee at a July 14 meeting in Bethesda, Md. Asked by the agency to discuss possible alternatives to the "Ask a Doctor Before Use" phrase suggested in FDA's proposed rule on OTC label reform, the committee members recommended a number of possible options, with "pharmacist" and "health care professional" receiving the most support. The group did not vote on the issue; NDAC Chairman Ralph D'Agostino, PhD, Boston University, instead polled individual members for their preferences.